Losartan, an angiotensin II type 1 receptor blocker, protects human islets from glucotoxicity through the phospholipase C pathway (Q46902241)
Jump to navigation
Jump to search
scientific article published on 5 September 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Losartan, an angiotensin II type 1 receptor blocker, protects human islets from glucotoxicity through the phospholipase C pathway |
scientific article published on 5 September 2013 |
Statements
1 reference
Losartan, an angiotensin II type 1 receptor blocker, protects human islets from glucotoxicity through the phospholipase C pathway (English)
1 reference
Anne-Marie Madec
1 reference
Roméo Cassel
1 reference
Séverine Dubois
1 reference
Sylvie Ducreux
1 reference
Marie-Agnès Chauvin
1 reference
Aurélia Mesnier
1 reference
Karim Chikh
1 reference
Domenico Bosco
1 reference
Fabien Van Coppenolle
1 reference
Charles Thivolet
1 reference
5 September 2013
1 reference
1 reference
27
1 reference
5122-5130
1 reference
12
1 reference
Identifiers
1 reference
1 reference